Valuation Lonza Group AG

Stocks

Market Closed - Swiss Exchange Other stock markets 09:00:32 10/07/2026 pm IST			5-day change	1st Jan Change
586.00 ^CHF	+0.58%		+2.06%	+8.96%

02/07	Nona Biosciences And Lonza Enter Strategic Collaboration To Develop Best-In-Class Single-Domain Antibody-Based BBB-Crossing Technology For CNS Diseases	CI
01/07	Lonza Group AG Expands Strategic Collaboration With Leading US Biopharmaceutical Company	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	56,574	33,615	26,273	38,699	37,769	40,691	-	-
Change	-	-40.58%	-21.84%	47.29%	-2.4%	7.74%	-	-
Enterprise Value (EV) ¹	55,616	33,429	27,195	41,558	41,027	43,906	43,608	43,239
Change	-	-39.89%	-18.65%	52.81%	-1.28%	7.02%	-0.68%	-0.84%
P/E	19.3x	27.7x	39.8x	60.1x	39.8x	34.9x	28.7x	23.7x
PBR	5.82x	3.18x	2.76x	4.1x	4.77x	4.46x	4.04x	3.62x
PEG	-	-0.5x	-0.9x	133.42x	0.8x	1.5x	1.3x	1.1x
Capitalization / Revenue	10.5x	5.4x	3.91x	5.89x	5.78x	5.7x	5.09x	4.54x
EV / Revenue	10.3x	5.37x	4.05x	6.32x	6.28x	6.15x	5.46x	4.83x
EV / EBITDA	33.4x	16.8x	13.6x	21.8x	19.9x	19x	16.5x	14.2x
EV / EBIT	48.3x	23.9x	29x	35.3x	29x	26.4x	22.2x	19x
EV / FCF	-449x	-39.2x	-91.6x	-291x	-189x	109x	71.7x	48.9x
FCF Yield	-0.22%	-2.55%	-1.09%	-0.34%	-0.53%	0.92%	1.4%	2.05%
Dividend per Share ²	3	3	4	4	5	5.447	6.222	7.07
Rate of return	0.39%	0.66%	1.13%	0.75%	0.93%	0.94%	1.07%	1.21%
EPS ²	39.52	16.34	8.88	8.92	13.51	16.68	20.29	24.59
Distribution rate	7.59%	18.4%	45%	44.8%	37%	32.7%	30.7%	28.8%
Net sales ¹	5,409	6,223	6,717	6,574	6,531	7,138	7,991	8,960
EBITDA ¹	1,665	1,995	1,999	1,908	2,064	2,309	2,650	3,054
EBIT ¹	1,151	1,397	939	1,177	1,417	1,663	1,963	2,276
Net income ¹	2,944	1,215	654	636	949	1,167	1,410	1,716
Net Debt ¹	-958	-186	922	2,859	3,258	3,215	2,916	2,548
Reference price ²	761.60	453.10	353.70	535.80	537.80	582.60	582.60	582.60
Nbr of stocks (in thousands)	74,283	74,189	74,282	72,226	70,229	69,844	-	-
Announcement Date	26/01/22	25/01/23	26/01/24	29/01/25	28/01/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
LONZA GROUP AG	35.02x	6.15x	19.02x	0.94%	5.04TCr
REVOLUTION MEDICINES, INC.	-23.93x	350.56x	-22.64x	-.--%	4.06TCr
IQVIA HOLDINGS INC.	25.43x	2.81x	12.14x	-.--%	3.49TCr
BEONE MEDICINES AG	46.36x	4.58x	29.24x	-.--%	3.37TCr
CELLTRION, INC.	26.73x	7.84x	19.68x	0.43%	2.63TCr
MEDPACE HOLDINGS, INC.	31.59x	5.09x	23.2x	-.--%	1.53TCr
IONIS PHARMACEUTICALS, INC.	-17.76x	11.63x	-17.23x	-.--%	1.06TCr
EUROFINS SCIENTIFIC SE	23.89x	2.03x	8.94x	1.12%	1.37TCr
ICON PUBLIC LIMITED COMPANY	23.89x	1.9x	11.51x	-.--%	1.29TCr
Average	19.02x	43.62x	9.32x	0.28%	2.65TCr
Weighted average by Cap.	20.45x	64.01x	10.09x	0.31%